Clinical trial
Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease: A Multicentre Randomised Controlled Trial
NCT04078568 is registered in ClinicalTrials.gov with Children's Hospital of Fudan University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease: A Multicentre Randomised Controlled Trial
- Lead sponsor
- Children's Hospital of Fudan University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 15, 2020
- Completion date
- November 6, 2025
- Enrollment
- 3,208 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
kawasaki disease